Otezla 55513-0137
Generic: Apremilast
Product NDC
55513-0137- Manufacturer
- Amgen, Inc
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 26, 2020
- Listing Expires
- December 31, 2027
- Application
- NDA205437
Need to source Otezla? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Apremilast | 30 mg/1 |
Drug Class
Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitor [EPC]Phosphodiesterase 4 Inhibitors [MoA]
Packaging Options(2)
60 TABLET, FILM COATED in 1 BOTTLE (55513-137-60)
1 BLISTER PACK in 1 CARTON (55513-137-95) / 28 TABLET, FILM COATED in 1 BLISTER PACK